personalized medicine

October 3, 2019

New test assists physicians with quicker treatment decisions for sepsis

Rapid blood culture diagnostics for patients with bacterial bloodstream infections delivered final results in 12 hours versus the two to three days required for conventional testing.

By Jessica Pasley
September 23, 2019

Tailoring treatment for heart defect

By defining the clinical and genetic factors that predict treatment response, Vanderbilt investigators aim to personalize therapy for a common heart complication in preterm infants.

By Leigh MacMillan
February 28, 2019

Personalized pain management

Understanding how natural brain chemicals with pain-relieving properties interact with administered opioids may guide personalized approaches for pain management.

By VUMC News and Communications
Lisa Bastarache, MS, Josh Denny, MD, MS, and colleagues are helping researchers study associations among de-identified genotype data and electronic health records data. (photo by John Russell)
February 7, 2019

PheWAS Core helps researchers make sense of electronic health record data

Some biomedical researchers may be unsure about routine electronic health record (EHR) data and how useful it ultimately may prove for drawing meaningful, actionable associations that warrant changes to clinical practice and lead to improved clinical outcomes.

By Paul Govern
June 21, 2018

Roden’s circulatory diseases research honored

Jun. 21, 2018—Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.

By Bill Snyder
June 21, 2018

Roden’s circulatory diseases research honored

Vanderbilt University’s Dan Roden, MD, internationally known for his contributions to understanding how genetic variation affects drug response, has been named a recipient of the 2018 Louis and Artur Lucian Award for Research in Circulatory Diseases by McGill University in Montreal, Canada.

By Bill Snyder
May 10, 2018

Event celebrates VUMC’s strong community ties

More than 300 members of the Canby Robinson Society and the Vanderbilt University Medical Center community joined Jeff Balser, MD, PhD, and his wife, Melinda, last week at Cheekwood Estate and Gardens for a reception celebrating the community of supporters who help VUMC in “redefining personalized care.”
By Nancy Humphrey
May 10, 2018

Launch event helps introduce ‘All of Us’ initiative to Nashville

On Sunday, May 6, Nashville played an important role in the nationwide launch of “All of Us,” the National Institutes of Health’s (NIH) research program that aims to collect the health information of 1 million or more research participants.
By John Howser
May 10, 2018

Storytelling initiative focuses on ‘Defining Personalized Care’

A new digital-first storytelling initiative, Defining Personalized Care, highlights the personal impact everyone at Vanderbilt Health makes with patients, families and each other.
By VUMC News and Communications
May 3, 2018

Gene study spots clues to heart risk for statin patients

A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol.
By Bill Snyder
May 3, 2018

Event set to launch ‘All of Us’ personalized medicine initiative

The All of Us Research Program, which aims to accelerate the prevention and treatment of illness through precision medicine with the help of a million or more research participants across the United States, officially opens for national enrollment Sunday, May 6.
By Bill Snyder
April 19, 2018

Former FDA official explores big data’s impact on healthcare

“Big data” can help reverse the alarming decline in life expectancy in the United States — if universities and academic medical centers take the lead, former U.S. Food and Drug Administrator Robert Califf, MD, told a Vanderbilt audience last week.
By Bill Snyder
April 5, 2018

Nashville Biosciences created to leverage wealth of data

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.
By Bill Snyder
1 2 3 4 5